Saturday 17 October 2026 Export TCRX’s income statement to Excel — free account

TScan Therapeutics, Inc.

TScan Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.3 million, up 266.7% from fiscal 2024. In the quarter to June 2026, revenue fell 65.8%, EPS grew 17.9%, free cash flow grew 19.0% and total debt rose 1.50%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.23 0.01 −4.17%

Follow TCRX

Alert me

Market cap: $16.2M
P/E: 0.0×
Fwd P/E: −1.1×
Dividend yield: —
F-score: 2/9
Altman Z: −3.54
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		28.05	12.57	14.36	17.91
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(7.28)	(4.06)	(5.40)	(4.62)
P/B ratio Full definition →		1.64	1.05	1.35	1.85
Price to Tangible BV Full definition →		1.64	1.05	1.35	1.85
EV/Sales Full definition →		11.23	1.96	5.05	8.43
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(0.72)	(0.15)	(0.38)	(0.52)
EV/FCF Full definition →		(0.70)	(0.14)	(0.37)	(0.51)
Quick Ratio Full definition →		6.32	8.15	6.41	3.23
Current Ratio Full definition →		6.44	8.41	6.65	3.37
Net Debt/EBITDA Full definition →		4.19	5.18	3.35	2.26
Debt/Assets Full definition →		12.36%	14.22%	16.17%	19.12%
Debt/Equity Full definition →		0.23	0.26	0.34	0.47
Asset Turnover Full definition →		0.03	0.03	0.03	0.03
Operating CF/Net income Full definition →		0.91	1.39	0.85	0.91
Capex/Depreciation Full definition →		(1.86)	(0.24)	(0.10)	(0.67)
Interest Coverage Full definition →		(53.01)	(33.99)	(42.29)	(43.62)
Research and Development Expense of Revenue Full definition →		1,262.01%	780.64%	2,230.55%	2,226.64%
Selling, General and Administrative Expense of Revenue Full definition →		313.58%	248.77%	836.76%	774.69%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		119.91%	78.22%	251.02%	224.26%
Graham Net Nets Full definition →		0.30	0.40	0.21	0.02
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(61.54%)	(100.00%)	(95.05%)	(92.86%)
Free Cash Flow Yield Full definition →		(57.49%)	(107.67%)	(95.23%)	(92.98%)
Revenue per Share Full definition →		0.02	0.02	0.01	0.01
Operating CF per Share Full definition →		(0.25)	(0.25)	(0.19)	(0.21)
Capex per Share Full definition →		(0.01)	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.26)	(0.25)	(0.19)	(0.22)
Cash per Share Full definition →		1.42	1.17	0.99	0.77
Shareholders Equity per Share Full definition →		1.11	0.95	0.75	0.53
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		1.11	0.95	0.75	0.53
Free Cash Flow Full definition →		(33.89)	(32.17)	(24.35)	(28.00)
Working Capital Full definition →		158.96	138.51	112.80	73.44
Capital Expenditures Full definition →		(1.42)	(0.17)	(0.07)	(0.46)
Net Current Asset Value Full definition →		69.96	51.54	27.70	1.97
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.57	0.07	0.07	0.44
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Payables Full definition →		5.00	2.76	3.63	3.83
Average Assets Full definition →		305.13	299.95	267.35	235.01
Average Common Equity Full definition →		186.55	182.05	153.56	122.87

Show all line items

Columns are period end dates

Stockrow Weekly